Medacta International obtained approval under the CE Mark for a lateralized glenosphere component, expanding its range of reverse shoulder replacement options.
The device features a more lateralized centre of rotation vs. the standard glenosphere presently marketed with the Medacta Shoulder. The lateralization can support an improved range of motion, as well as a reduced risk of scapular notching.
Medacta’s modular shoulder system, pictured below, includes a range of sizes, adjustable offset and anatomic and reverse configurations. It is compatible with the company’s CT-based MyShoulder 3D preoperative planning solution, with patient-specific humeral and glenoid guides.
Source: Medacta
Medacta International obtained approval under the CE Mark for a lateralized glenosphere component, expanding its range of reverse shoulder replacement options.
The device features a more lateralized centre of rotation vs. the standard glenosphere presently marketed with the Medacta Shoulder. The lateralization can support an improved range...
Medacta International obtained approval under the CE Mark for a lateralized glenosphere component, expanding its range of reverse shoulder replacement options.
The device features a more lateralized centre of rotation vs. the standard glenosphere presently marketed with the Medacta Shoulder. The lateralization can support an improved range of motion, as well as a reduced risk of scapular notching.
Medacta’s modular shoulder system, pictured below, includes a range of sizes, adjustable offset and anatomic and reverse configurations. It is compatible with the company’s CT-based MyShoulder 3D preoperative planning solution, with patient-specific humeral and glenoid guides.
Source: Medacta
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
